InvestorsHub Logo
icon url

Whalatane

04/06/20 10:45 AM

#262925 RE: bfost #262915

bfost ..thx ...hopefully everyone understands that now ...

in case anyone missed it ...from Bfost

it doesn't matter what the doctor prescribes.
What matters is what the insurers formulary GIVES to the patient.
If the formulary software says generic V is on the formulary then generic V is given - regardless that the doc wrote for brand Vascepa.



So I'll assume that if Teva's generic V is a $1 less per month than Hikma's generic V ....Teva's generic V is what the patient gets

Kiwi
icon url

johnking29

04/06/20 11:21 AM

#262951 RE: bfost #262915

Then the question is will they List Generic Vascepa as an acceptable use for Cardiovasular Conditions?

JL already replied with his position...
icon url

Cardiologymd

04/06/20 11:31 AM

#262956 RE: bfost #262915

Exactly

Amarin can forget about the US market if appeal gets rejected

Every brand vascepa will be exchanged for generic by pharmacist.